These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32556345)

  • 1. Delusional Infestation Can Be a Complication of Prurigo Nodularis with Underlying Neuropathies.
    Dervout C; Stephan F; Misery L
    Acta Derm Venereol; 2020 Jul; 100(14):adv00217. PubMed ID: 32556345
    [No Abstract]   [Full Text] [Related]  

  • 2. Dermal Periostin: A New Player in Itch of Prurigo Nodularis.
    Hashimoto T; Nattkemper LA; Kim HS; Kursewicz CD; Fowler E; Shah SM; Nanda S; Fayne RA; Romanelli P; Yosipovitch G
    Acta Derm Venereol; 2021 Jan; 101(1):adv00375. PubMed ID: 33236123
    [No Abstract]   [Full Text] [Related]  

  • 3. Dupilumab Significantly Reduces Symptoms of Prurigo Nodularis and Depression: A Case Series.
    Lönndahl L; Lundqvist M; Bradley M; Johansson EK
    Acta Derm Venereol; 2022 Aug; 102():adv00754. PubMed ID: 35670328
    [No Abstract]   [Full Text] [Related]  

  • 4. Epidemiology of Prurigo Nodularis compared with Psoriasis in Germany: A Claims Database Analysis.
    Ständer S; Ketz M; Kossack N; Akumo D; Pignot M; Gabriel S; Chavda R
    Acta Derm Venereol; 2020 Nov; 100(18):adv00309. PubMed ID: 33021323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of prurigo nodularis, chronic prurigo and neurodermatitis circumscripta with topical capsaicin.
    Tupker RA; Coenraads PJ; van der Meer JB
    Acta Derm Venereol; 1992 Nov; 72(6):463. PubMed ID: 1362846
    [No Abstract]   [Full Text] [Related]  

  • 6. Nemolizumab: An Innovative Biologic Treatment to Control Interleukin 31, a Key Mediator in Atopic Dermatitis and Prurigo Nodularis.
    Serra-Baldrich E; Santamaría-Babí LF; Francisco Silvestre J
    Actas Dermosifiliogr; 2022; 113(7):674-684. PubMed ID: 35842249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurohistological studies on the differential diagnosis of prurigo nodularis Hyde and of other forms of circumscribed lichenification].
    THIES W
    Arch Klin Exp Dermatol; 1955; 201(6):539-55. PubMed ID: 13303208
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of lenalidomide in treating refractory prurigo nodularis.
    Liu H; Gaspari AA; Schleichert R
    J Drugs Dermatol; 2013 Mar; 12(3):360-1. PubMed ID: 23545923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prurigo nodularis: New treatments on the horizon.
    Yosipovitch G
    J Am Acad Dermatol; 2020 Apr; 82(4):1035-1036. PubMed ID: 32172924
    [No Abstract]   [Full Text] [Related]  

  • 10. A case for diagnosis; lichen obtusus? prurigo nodularis?
    ROTHMAN S
    Arch Derm Syphilol; 1948 Mar; 57(3 Pt. 2):477-9. PubMed ID: 18207886
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of Itch on Sleep Disturbance in Patients with Prurigo Nodularis.
    Gwillim EC; Nattkemper L; Yosipovitch G
    Acta Derm Venereol; 2021 Mar; 101(3):adv00424. PubMed ID: 33704503
    [No Abstract]   [Full Text] [Related]  

  • 12. A case for diagnosis; prurigo nodularis? filariasis? lichen planus? scabies?
    THOMAS CC; WHELAN SC
    Arch Derm Syphilol; 1948 Mar; 57(3 Pt. 2):411. PubMed ID: 18207750
    [No Abstract]   [Full Text] [Related]  

  • 13. Dupilumab in prurigo nodularis: a systematic review of current evidence and analysis of predictive factors to response.
    Husein-ElAhmed H; Steinhoff M
    J Dermatolog Treat; 2022 May; 33(3):1547-1553. PubMed ID: 33200955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prurigo Nodularis: Review and Emerging Treatments.
    Leis M; Fleming P; Lynde CW
    Skin Therapy Lett; 2021 May; 26(3):5-8. PubMed ID: 34077168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbidities of Prurigo Nodularis in Finland Between 1996 and 2019.
    Wikström K; Verkko H; Sinikumpu SP; Jokelainen J; Tasanen K; Huilaja L
    Acta Derm Venereol; 2021 Jul; 101(7):adv00508. PubMed ID: 34230981
    [No Abstract]   [Full Text] [Related]  

  • 16. Response: Management challenges in prurigo nodularis.
    Fernandez JM; Hurlbert MG; Shi VY
    J Dermatolog Treat; 2022 Feb; 33(1):583-584. PubMed ID: 32068455
    [No Abstract]   [Full Text] [Related]  

  • 17. Baseline eosinophil level may be a predictive indicator for the effectiveness of dupilumab in patients with prurigo nodularis: A single-center, real-world prospective study.
    Yi X; Cao Q; Peng C; Jia Q; Li J
    J Am Acad Dermatol; 2024 May; 90(5):1076-1078. PubMed ID: 38296194
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of Paediatric Prurigo Nodularis: A Multicentre Retrospective, Observational Study.
    Kyvayko R; Fachler-Sharp T; Greenberger S; Horev A; Molho-Pessach V
    Acta Derm Venereol; 2024 Feb; 104():adv15771. PubMed ID: 38299231
    [No Abstract]   [Full Text] [Related]  

  • 19. Emerging novel therapeutic agents for the treatment of patients with prurigo nodularis.
    Maredia H; Kwatra SG
    J Dermatolog Treat; 2021 Nov; 32(7):741-744. PubMed ID: 31900001
    [No Abstract]   [Full Text] [Related]  

  • 20. Langerhans cell histiocytosis mimicking prurigo nodularis.
    Traidl S; Angela Y; Wedi B; Kapp A; Werfel T; Schacht V
    J Eur Acad Dermatol Venereol; 2021 Apr; 35(4):e259-e261. PubMed ID: 33040393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.